1. Cooper, A. J. L. and Kristal, B. S. 1997. Multiple roles of glutathione in the central nervous system. Biol. Chem. 378:793–802. 22.
2. Dringen, R., Kussmaul, L., Gutterer, J. M., Hirrlinger, J. and
Hamprecht, B. 1999. The glutathione system of peroxide detoxification is less efficient in neurons than in astroglial cells.
J. Neurochem. 72:2523–2530. 23.
3. Hall, A. 1999. The role of glutathione in the regulation of apotosis. Eur. J. Clin. Invest. 29:238–245.
4. Lange, K. W. 1998. Clinical pharmacology of dopamine ago- 24.
nists in Parkinson's disease. Drug Aging 13:381–389.
5. Ogawa, N. 1998. Early introduction of dopamine agonists in
the long-term treatment of Parkinson's disease. Neurology 25.
51(Suppl 2):S13–S20.
Lange, K. W., Rausch, W.-D., Gsell, W., Naumann, M., Oestreicher, E., and Riederer, P. 1994. Neuroprotection by dopamine
agonists. J. Neural Transm. (Suppl 43):183–201.
